Zheng HX, Wu LN, Xiao H, Du Q, Liang JF. Inhibitory effects of dobutamine on human gastric adenocarcinoma. World J Gastroenterol 2014; 20(45): 17092-17099 [PMID: 25493021 DOI: 10.3748/wjg.v20.i45.17092]
Corresponding Author of This Article
Jian-Fang Liang, MD, Chief Physician, Department of Pathology, The First Hospital, Shanxi Medical University, No. 85 South Jiefang Road, Taiyuan 030024, Shanxi Province, China. liangjianfang2000@163.com
Research Domain of This Article
Medicine, Research & Experimental
Article-Type of This Article
Research Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/